Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054-Reference-Cited by-同舟云学术

Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054

Published:2019-06-17 Issue:8 Volume:34 Page:1154-1163
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Brys Miroslaw¹^ORCID,Fanning Laura¹,Hung Serena¹,Ellenbogen Aaron²³,Penner Natalia¹,Yang Minhua¹,Welch Mackenzie¹,Koenig Erica¹,David Eric¹,Fox Tara⁴,Makh Shavy⁴,Aldred Jason⁵,Goodman Ira⁶,Pepinsky Blake¹,Liu YuTing¹,Graham Danielle¹,Weihofen Andreas¹,Cedarbaum Jesse M.¹

Affiliation:

1. Biogen Cambridge Massachusetts USA

2. Michigan Institute for Neurological Disorders Farmington Hills Michigan USA

3. QUEST Research Institute Farmington Michigan USA

4. Biogen Maidenhead UK

5. Selkirk Neurology & Inland Northwest Neurological Spokane Washington USA

6. The Compass Clinic Orlando Florida USA

Funder

Biogen

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27738

Reference21 articles.

1. National Institute of Neurological Disorders and Stroke National Institutes of Health. Parkinson's disease: challenges progress and promise.https://www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-Disease-Challenges-Progress-and-Promise. Accessed January 4 2019.

2. The Parkinson Pandemic—A Call to Action

3. Medical and surgical management of advanced Parkinson's disease

4. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

5. Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cinpanemab in Early Parkinson Disease;Neurology;2024-03-12

2. Recombinant Antibody Fragments for Immunotherapy of Parkinson’s Disease;BioDrugs;2024-01-27

3. A Randomized, Double Blind, Placebo-Controlled Study in Patients with Parkinson's Disease with an Alpha-Synuclein Vaccine UB-312;2024

4. Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders;Biomedicines;2023-10-14

5. The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease;International Journal of Molecular Sciences;2023-09-26